Biotechnology Media, Sera And Reagents Market Overview:
The global biotechnology media, sera and reagents market was valued at $18,794 million in 2017 and is estimated to reach at $32,974 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.
Biotechnology is the branch of science that uses living organisms to make technological advancements and adapt those technologies to various different fields including agriculture, genetic engineering, novel drug developments, and several others. Media and sera find their application in animal tissue culture and plant tissue culture, while reagents are used in various biotechnology applications such as diagnosis, laboratory research, drug development, and others.
Considerable rise in the biotechnological R&D pertaining to the development of biopharmaceuticals has led to an increase in demand for culture media, sera, and reagents market. Moreover, increase in investments and funding for research interventions in both developed and developing countries further boost the market growth. However, ethical & scientific concerns associated with the potential of misuse of biotechnology research practices and dearth of skilled personnel restrict the market growth. On the contrary, untapped potential of the emerging economies is anticipated to provide lucrative opportunities to the key players involved in the biotechnology media, sera and reagents market in the near future.
The biotechnology media, sera and reagents media market is segmented based on type, application, end user, and region. Based on type, the market is divided into media, sera and reagents. The media segment is further bifurcated into lysogeny broth, classical media, serum free media, chemically defined media, specialty media, stem cell media and others. The sera segment is further classified into fetal bovine sera, new born calf sera, and others. Likewise, the reagents segment is further segmented into antibiotics, DNA/RNS isolation reagents, PCR reagents, buffers and others. Based on application, the market is categorized into cancer research, biopharmaceuticals, clinical diagnostics, regenerative medicine & tissue engineering, and others. Based on end user, it is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Biotechnology Media, Sera And Reagents Market:
The study provides an in-depth analysis of the global biotechnology media, sera and reagents market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the biotechnology media, sera and reagents market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Biotechnology Media, Sera And Reagents Key Market Segments:
By Type
Media
Lysogeny Broth
Classical Media
Serum Free Media
Chemically Defined Media
Specialty Media
Stem Cell Media
Others
Sera
Fetal Bovine Sera
New Born Calf Sera
Others
Reagents
Antibiotics
DNA/RNS Isolation Reagents
PCR Reagents
Buffers
Others
By Application
Cancer Research
Biopharmaceuticals
Regenerative Medicine & Tissue Engineering
Others
By End User
Biotechnology & Pharmaceutical Companies
Academic Institute
Research Laboratory
Others
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
France
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA
Key Market Players
GE Healthcare
Bio-Rad Laboratories Inc.
Merck KGaA (Sigma Aldrich)
Sartorius AG
HiMedia Laboratories Pvt., Ltd
Lonza Group Ltd
Merck & Co., Inc.
Thermofisher Scientific
Corning Incorporated
Becton, Dickinson and Company
The other players in the value chain include (profiles not included in the report)
Avantor Performance Materials, LLC
Caisson Laboratories, Inc
Cell Culture Technologies LLC
Fujifilm Holdings Corporation
Sera Scandia A/S (Biowest)
Vitro Diagnostics, Inc.
Cyagen Biosciences
The global biotechnology media, sera and reagents market was valued at $18,794 million in 2017 and is estimated to reach at $32,974 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.
Biotechnology is the branch of science that uses living organisms to make technological advancements and adapt those technologies to various different fields including agriculture, genetic engineering, novel drug developments, and several others. Media and sera find their application in animal tissue culture and plant tissue culture, while reagents are used in various biotechnology applications such as diagnosis, laboratory research, drug development, and others.
Considerable rise in the biotechnological R&D pertaining to the development of biopharmaceuticals has led to an increase in demand for culture media, sera, and reagents market. Moreover, increase in investments and funding for research interventions in both developed and developing countries further boost the market growth. However, ethical & scientific concerns associated with the potential of misuse of biotechnology research practices and dearth of skilled personnel restrict the market growth. On the contrary, untapped potential of the emerging economies is anticipated to provide lucrative opportunities to the key players involved in the biotechnology media, sera and reagents market in the near future.
The biotechnology media, sera and reagents media market is segmented based on type, application, end user, and region. Based on type, the market is divided into media, sera and reagents. The media segment is further bifurcated into lysogeny broth, classical media, serum free media, chemically defined media, specialty media, stem cell media and others. The sera segment is further classified into fetal bovine sera, new born calf sera, and others. Likewise, the reagents segment is further segmented into antibiotics, DNA/RNS isolation reagents, PCR reagents, buffers and others. Based on application, the market is categorized into cancer research, biopharmaceuticals, clinical diagnostics, regenerative medicine & tissue engineering, and others. Based on end user, it is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Biotechnology Media, Sera And Reagents Market:
The study provides an in-depth analysis of the global biotechnology media, sera and reagents market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the biotechnology media, sera and reagents market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Biotechnology Media, Sera And Reagents Key Market Segments:
By Type
Media
Lysogeny Broth
Classical Media
Serum Free Media
Chemically Defined Media
Specialty Media
Stem Cell Media
Others
Sera
Fetal Bovine Sera
New Born Calf Sera
Others
Reagents
Antibiotics
DNA/RNS Isolation Reagents
PCR Reagents
Buffers
Others
By Application
Cancer Research
Biopharmaceuticals
Regenerative Medicine & Tissue Engineering
Others
By End User
Biotechnology & Pharmaceutical Companies
Academic Institute
Research Laboratory
Others
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
France
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA
Key Market Players
GE Healthcare
Bio-Rad Laboratories Inc.
Merck KGaA (Sigma Aldrich)
Sartorius AG
HiMedia Laboratories Pvt., Ltd
Lonza Group Ltd
Merck & Co., Inc.
Thermofisher Scientific
Corning Incorporated
Becton, Dickinson and Company
The other players in the value chain include (profiles not included in the report)
Avantor Performance Materials, LLC
Caisson Laboratories, Inc
Cell Culture Technologies LLC
Fujifilm Holdings Corporation
Sera Scandia A/S (Biowest)
Vitro Diagnostics, Inc.
Cyagen Biosciences
Frequently Asked Questions about the Global Biotechnology Media, Sera and Reagents Market
What is the estimated value of the Global Biotechnology Media, Sera and Reagents Market?
What is the growth rate of the Global Biotechnology Media, Sera and Reagents Market?
What is the forecasted size of the Global Biotechnology Media, Sera and Reagents Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 240 |
| Published | February 2019 |
| Forecast Period | 2017 - 2025 |
| Estimated Market Value ( USD | $ 18794 million |
| Forecasted Market Value ( USD | $ 32974 million |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE
CHAPTER 5: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET BY APPLICATION
CHAPTER 6: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER
CHAPTER 7: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
Executive Summary
According to this report titled 'Biotechnology Media, Sera and Reagent Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,' the global biotechnology media, sera and reagents market was valued at $18,794 million in 2017 and is projected to reach $32,974 million by 2025, growing at a CAGR of 7.3% from 2018 to 2025. North America was the highest revenue contributor in 2017 and would remain the same throughout the forecast period.Biotechnology is the branch of science that deals with the study of living organisms and their use to make technological innovations. Media is a nutrient growth substance provided in laboratory and research settings for growth, proliferation, maintenance, and storage of microorganisms and other cell types such as stem cells, mammalian, and other cell lines. Different culture media are available in the market for various cell cultures to survive and grow in their incubation environment such as lysogeny broth, serum free media, classical media, chemically defined media among others. In addition, sera are used as additional growth supplement factors owing to the presence of hormones necessary for cell growth, proliferation, and differentiation of cells. Further, reagent is a substance that is used to cause a chemical reaction. Reagents are often used to indicate the presence of another substance.
Based on biotechnology media, sera and reagents market trends by type, the reagent segment accounted for the majority of market share of the global market in 2017. This is attributed to the fact that reagents find their wide applications in all most biotechnological research such as cell culture, biopharmaceutical research and others.
Based on end user, the biotechnology and pharmaceutical company generated the maximum revenue of in 2017. This segment is anticipated to exhibit prominent growth rate, due to significant rise in R&D for the development of biopharmaceutical drugs and cancer research.
Key Findings of the Biotechnology Media, Seraand Reagent Market:
Based on end user, research laboratories accounted for nearly one-third share of the biotechnology media, sera and reagents industry in 2017.
The biopharmaceuticals application segment is anticipated to grow with the highest CAGR throughout the forecast period.
Based on region, North America accounted for nearly two-fifth of the global biotechnology media, sera and reagents market share in 2017.
Asia-Pacific is anticipated to grow at the highest rate in the biotechnology media, sera and reagents market during the analysis period, followed by LAMEA.
North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers, surge in R&D expenditure for the development of biotechnology media, seraand reagent, and growth in prevalence of food allergies. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase awareness & availability about different reagents & media in the market, increase in biotech R&D, and growth in presence of key market players in this region.
The report provides an extensive competitive analysis and profiles of the key market players, such as GE Healthcare, Bio-Rad laboratories Inc., Merck KGaA (Sigma Aldrich), Sartorius AG, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, Merck & Co., Inc., Thermofisher Scientific, Corning Incorporated, Becton, Dickinson and Company. The other players in the value chain (not included in the report) are Takara Bio, Inc., Cyagen Biosciences, PeproTech, Inc., Avantor Performance Materials, LLC (VWR International, LLC), Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
